
### [NCIT:C4911](http://purl.obolibrary.org/obo/NCIT_C4911)
**Label:** Gastric Carcinoma

**Subclasses:** [NCIT:C7788](http://purl.obolibrary.org/obo/NCIT_C7788) (Stage 0 Gastric Cancer AJCC v6 and v7), [NCIT:C27131](http://purl.obolibrary.org/obo/NCIT_C27131) (Early Gastric Cancer), [NCIT:C5248](http://purl.obolibrary.org/obo/NCIT_C5248) (Mucinous Gastric Adenocarcinoma), [NCIT:C95884](http://purl.obolibrary.org/obo/NCIT_C95884) (Gastric Neuroendocrine Carcinoma), [NCIT:C95763](http://purl.obolibrary.org/obo/NCIT_C95763) (Gastric Intramucosal Adenocarcinoma), [NCIT:C89859](http://purl.obolibrary.org/obo/NCIT_C89859) (Stage II Gastric Cancer AJCC v7), [NCIT:C4430](http://purl.obolibrary.org/obo/NCIT_C4430) (Gastric Body Carcinoma In Situ AJCC v6 and v7), [NCIT:C8399](http://purl.obolibrary.org/obo/NCIT_C8399) (Gastric Body Carcinoma), [NCIT:C6795](http://purl.obolibrary.org/obo/NCIT_C6795) (Gastric Pylorus Carcinoma), [NCIT:C4431](http://purl.obolibrary.org/obo/NCIT_C4431) (Gastric Pylorus Carcinoma In Situ AJCC v6 and v7), [NCIT:C95748](http://purl.obolibrary.org/obo/NCIT_C95748) (Gastric Carcinoma with Lymphoid Stroma), [NCIT:C67526](http://purl.obolibrary.org/obo/NCIT_C67526) (Gastric Mixed Adenocarcinoma), [NCIT:C95747](http://purl.obolibrary.org/obo/NCIT_C95747) (Gastric Hepatoid Adenocarcinoma), [NCIT:C43527](http://purl.obolibrary.org/obo/NCIT_C43527) (Sporadic Gastric Adenocarcinoma), [NCIT:C43529](http://purl.obolibrary.org/obo/NCIT_C43529) (Sporadic Diffuse Gastric Adenocarcinoma), [NCIT:C91222](http://purl.obolibrary.org/obo/NCIT_C91222) (Gastric Cancer by AJCC v7 Stage), [NCIT:C89856](http://purl.obolibrary.org/obo/NCIT_C89856) (Stage I Gastric Cancer AJCC v7), [NCIT:C95743](http://purl.obolibrary.org/obo/NCIT_C95743) (Poorly Cohesive Gastric Carcinoma), [NCIT:C95886](http://purl.obolibrary.org/obo/NCIT_C95886) (Gastric Mixed Adenoneuroendocrine Carcinoma), [NCIT:C95885](http://purl.obolibrary.org/obo/NCIT_C95885) (Gastric Large Cell Neuroendocrine Carcinoma), [NCIT:C4004](http://purl.obolibrary.org/obo/NCIT_C4004) (Gastric Adenocarcinoma), [NCIT:C6764](http://purl.obolibrary.org/obo/NCIT_C6764) (Gastric Small Cell Neuroendocrine Carcinoma), [NCIT:C43295](http://purl.obolibrary.org/obo/NCIT_C43295) (Hereditary Diffuse Gastric Adenocarcinoma), [NCIT:C5473](http://purl.obolibrary.org/obo/NCIT_C5473) (Gastric Tubular Adenocarcinoma), [NCIT:C7773](http://purl.obolibrary.org/obo/NCIT_C7773) (Stage II Gastric Cancer AJCC v6), [NCIT:C9237](http://purl.obolibrary.org/obo/NCIT_C9237) (Recurrent Gastric Carcinoma), [NCIT:C7772](http://purl.obolibrary.org/obo/NCIT_C7772) (Stage I Gastric Cancer AJCC v6), [NCIT:C5474](http://purl.obolibrary.org/obo/NCIT_C5474) (Gastric Adenosquamous Carcinoma), [NCIT:C5475](http://purl.obolibrary.org/obo/NCIT_C5475) (Gastric Squamous Cell Carcinoma), [NCIT:C5476](http://purl.obolibrary.org/obo/NCIT_C5476) (Undifferentiated Gastric Carcinoma), [NCIT:C8400](http://purl.obolibrary.org/obo/NCIT_C8400) (Gastric Antrum Carcinoma In Situ AJCC v6 and v7), [NCIT:C9159](http://purl.obolibrary.org/obo/NCIT_C9159) (Diffuse Gastric Adenocarcinoma), [NCIT:C7774](http://purl.obolibrary.org/obo/NCIT_C7774) (Stage III Gastric Cancer AJCC v6), [NCIT:C27765](http://purl.obolibrary.org/obo/NCIT_C27765) (Helicobacter Pylori-Related Gastric Adenocarcinoma), [NCIT:C5250](http://purl.obolibrary.org/obo/NCIT_C5250) (Signet Ring Cell Gastric Adenocarcinoma), [NCIT:C9157](http://purl.obolibrary.org/obo/NCIT_C9157) (Gastric Intestinal-Type Adenocarcinoma), [NCIT:C9036](http://purl.obolibrary.org/obo/NCIT_C9036) (Stage IV Gastric Cancer AJCC v6), [NCIT:C5472](http://purl.obolibrary.org/obo/NCIT_C5472) (Gastric Papillary Adenocarcinoma), [NCIT:C89861](http://purl.obolibrary.org/obo/NCIT_C89861) (Stage IV Gastric Cancer AJCC v7), [NCIT:C89860](http://purl.obolibrary.org/obo/NCIT_C89860) (Stage III Gastric Cancer AJCC v7), [NCIT:C133638](http://purl.obolibrary.org/obo/NCIT_C133638) (Gastric Cancer by AJCC v8 Stage), [NCIT:C118813](http://purl.obolibrary.org/obo/NCIT_C118813) (Childhood Gastric Carcinoma), [NCIT:C90503](http://purl.obolibrary.org/obo/NCIT_C90503) (Gastric Cancer by AJCC v6 Stage), 

**Class expressions from DL-Learner:**

- Thing 54.31%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C36493](http://purl.obolibrary.org/obo/NCIT_C36493) (High-Frequency Microsatellite Instability))) 52.78%
- [NCIT:C48189](http://purl.obolibrary.org/obo/NCIT_C48189) (Genomic Instability) 38.13%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) 38.13%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C39054](http://purl.obolibrary.org/obo/NCIT_C39054) (Extracellular Matrix Binding Pathway))) 38.13%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C39040](http://purl.obolibrary.org/obo/NCIT_C39040) (CTCF Pathway))) 38.13%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C39021](http://purl.obolibrary.org/obo/NCIT_C39021) (Cell Migration Pathway))) 38.13%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C39016](http://purl.obolibrary.org/obo/NCIT_C39016) (EGF Receptor Downregulation by CBL Pathway))) 38.13%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C39013](http://purl.obolibrary.org/obo/NCIT_C39013) (Estrogen Receptor Regulation by CARM1 Pathway))) 38.13%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C39011](http://purl.obolibrary.org/obo/NCIT_C39011) (Cardiac Hypertrophy Pathway))) 38.13%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C3901](http://purl.obolibrary.org/obo/NCIT_C3901) (Compound Nevus))) 38.13%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C39006](http://purl.obolibrary.org/obo/NCIT_C39006) (Bioactive Peptide Signaling Pathway))) 38.13%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C39004](http://purl.obolibrary.org/obo/NCIT_C39004) (B-Cell Survival Pathway))) 38.13%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C38999](http://purl.obolibrary.org/obo/NCIT_C38999) (BARD1 Pathway))) 38.13%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C38998](http://purl.obolibrary.org/obo/NCIT_C38998) (BAD Regulation Pathway))) 38.13%


